Antler Bio Raises £3m to Scale EpiHerd for European Dairy Farms

Antler Bio, an agtech startup, has successfully raised $4.3 million (£3.1 million) from investors including The First Thirty Ventures, Endgame Capital, and Generation-RE. This funding will be used to scale up its EpiHerd technology, an advanced data analytics system that interprets how bovine genes respond to environmental conditions. Operating in key European dairy markets such as the UK, Finland, Sweden, and Denmark, EpiHerd helps farmers proactively manage cattle health, improving animal wellbeing and milk yield. The First Thirty Ventures, represented by Naeem Lakhani, supports Antler Bio's ambitious vision to combine biology and technology, thus leading to enhanced farm efficiency and better nutrition for consumers. The investment will allow Antler Bio to expand its market presence and continue developing its technology.